Review the latest on shared clinical decision-making as it applies to pneumococcal vaccination. Hear from vaccine experts Lauren B. Angelo, PharmD, MBA, Michael Hogue, PharmD, FAPhA, FNAP, and Miranda Wilhelm, PharmD who will discuss the Advisory Committee on Immunization Practices (ACIP) updated recommendations for the 13-valent pneumococcal conjugate vaccine (PCV13).
At the completion of this learning activity, participants will be able to:
- Define shared clinical decision-making (SCDM).
- Describe the Advisory Committee on Immunization Practices (ACIP) recommendations for SCDM and pneumococcal vaccinations.
- Apply SCDM to patients with specific characteristics for whom PCV13 should be considered.
- Discuss the pharmacist’s role when applying SCDM to immunization recommendations.
Target audience: Pharmacists
Initial release date: December 8, 2020
Expiration date: December 8, 2023
Development and Support
Initiatives to Support Pneumococcal Vaccination and Shared Clinical Decision-Making in Pharmacy Practice is a non-CPE learning activity for pharmacists developed by the American Pharmacists Association and supported by an educational grant from Pfizer. © 2020 American Pharmacists Association
Lauren B. Angelo, PharmD, MBA declares that she is (1) an educational speaker for Seqirus, Inc. and (2) a clinical consultant for Wolters Kluwer.
Miranda Wilhelm, PharmD; Michael Hogue, PharmD, FAPhA, FNAP; and APhA's editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
There is no fee associated with this activity. This online learning activity is open to APhA members and nonmembers.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.